Status:
COMPLETED
Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic Etiology
Lead Sponsor:
Sanofi
Conditions:
Urinary Bladder Neurogenic
Eligibility:
All Genders
2-16 years
Phase:
PHASE3
Brief Summary
The primary objective is to investigate the pharmacokinetics (PK) of 2 doses of alfuzosin (given as a solution or tablets depending on age) in children and adolescents 2 to 16 years of age with elevat...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Children and adolescents of either gender 2-16 years of age with elevated detrusor LPP of neuropathic etiology.
Exclusion
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2007
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT00629720
Start Date
July 1 2006
End Date
February 1 2007
Last Update
December 15 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanofi-Aventis Administrative Office
Malvern, Pennsylvania, United States, 19355
2
Sanofi-Aventis Administrative Office
Belgrade, Serbia